80 related articles for article (PubMed ID: 8432528)
41. Assignment1 of the ubiquitin conjugating enzyme gene, UBE2G2, to human chromosome band 21q22.3 by in situ hybridization.
Rose SA; Leek JP; Moynihan TP; Ardley HC; Markham AF; Robinson PA
Cytogenet Cell Genet; 1998; 83(1-2):98-9. PubMed ID: 9925943
[No Abstract] [Full Text] [Related]
42. Down syndrome with duplication of a region of chromosome 21 containing the CuZn superoxide dismutase gene without detectable karyotypic abnormality.
Huret JL; Delabar JM; Marlhens F; Aurias A; Nicole A; Berthier M; Tanzer J; Sinet PM
Hum Genet; 1987 Mar; 75(3):251-7. PubMed ID: 2951317
[TBL] [Abstract][Full Text] [Related]
43. Expression of the DYRK1A gene correlates with its 3D positioning in the interphase nucleus of Down syndrome cells.
Paz N; Felipe-Blanco I; Royo F; Zabala A; Guerra-Merino I; García-Orad Á; Zugaza JL; Parada LA
Chromosome Res; 2015 Jun; 23(2):285-98. PubMed ID: 25645734
[TBL] [Abstract][Full Text] [Related]
44. Increased brain protein levels of carbonyl reductase and alcohol dehydrogenase in Down syndrome and Alzheimer's disease.
Balcz B; Kirchner L; Cairns N; Fountoulakis M; Lubec G
J Neural Transm Suppl; 2001; (61):193-201. PubMed ID: 11771743
[TBL] [Abstract][Full Text] [Related]
45. Localization of multiple human dihydrodiol dehydrogenase (DDH1 and DDH2) and chlordecone reductase (CHDR) genes in chromosome 10 by the polymerase chain reaction and fluorescence in situ hybridization.
Khanna M; Qin KN; Klisak I; Belkin S; Sparkes RS; Cheng KC
Genomics; 1995 Jan; 25(2):588-90. PubMed ID: 7789999
[TBL] [Abstract][Full Text] [Related]
46. Functional significance of a natural allelic variant of human carbonyl reductase 3 (CBR3).
Lakhman SS; Ghosh D; Blanco JG
Drug Metab Dispos; 2005 Feb; 33(2):254-7. PubMed ID: 15537833
[TBL] [Abstract][Full Text] [Related]
47. Evaluation of the Effect of Uremic Serum on Hepatic Reductase Functional Expression.
Alshogran OY; Al-Obaidi EAF; Al-Husein BA; Oweis AO
Drug Metab Lett; 2018; 12(1):75-81. PubMed ID: 29658443
[TBL] [Abstract][Full Text] [Related]
48. Correction to "Quantitative Analysis of mRNA and Protein Expression Levels of Aldo-Keto Reductase and Short-Chain Dehydrogenase/Reductase Isoforms in the Human Intestine".
Drug Metab Dispos; 2024 Jun; 52(7):703. PubMed ID: 38886027
[No Abstract] [Full Text] [Related]
49. Role of DNA Methylation on the Expression of the Anthracycline Metabolizing Enzyme AKR7A2 in Human Heart.
Hoefer CC; Quiñones-Lombraña A; Blair RH; Blanco JG
Cardiovasc Toxicol; 2016 Apr; 16(2):182-92. PubMed ID: 25962911
[TBL] [Abstract][Full Text] [Related]
50. Oxidative burst intensity of peripheral phagocytic cells and periodontitis in Down syndrome.
Khocht A; Russell B; Cannon JG; Turner B; Janal M
J Periodontal Res; 2014 Feb; 49(1):29-35. PubMed ID: 23488730
[TBL] [Abstract][Full Text] [Related]
51. Proteomic validation of multifunctional molecules in mesenchymal stem cells derived from human bone marrow, umbilical cord blood and peripheral blood.
Kim J; Shin JM; Jeon YJ; Chung HM; Chae JI
PLoS One; 2012; 7(5):e32350. PubMed ID: 22615730
[TBL] [Abstract][Full Text] [Related]
52. Phagocytic cell activity and periodontitis in Down syndrome.
Khocht A; Russell B; Cannon JG; Turner B; Janal M
Oral Dis; 2012 May; 18(4):346-52. PubMed ID: 22126098
[TBL] [Abstract][Full Text] [Related]
53. Redox proteomics in selected neurodegenerative disorders: from its infancy to future applications.
Butterfield DA; Perluigi M; Reed T; Muharib T; Hughes CP; Robinson RA; Sultana R
Antioxid Redox Signal; 2012 Dec; 17(11):1610-55. PubMed ID: 22115501
[TBL] [Abstract][Full Text] [Related]
54. 4-Hydroxy-2-nonenal, a reactive product of lipid peroxidation, and neurodegenerative diseases: a toxic combination illuminated by redox proteomics studies.
Perluigi M; Coccia R; Butterfield DA
Antioxid Redox Signal; 2012 Dec; 17(11):1590-609. PubMed ID: 22114878
[TBL] [Abstract][Full Text] [Related]
55. Expression of the anthracycline-metabolizing enzyme carbonyl reductase 1 in hearts from donors with Down syndrome.
Kalabus JL; Sanborn CC; Jamil RG; Cheng Q; Blanco JG
Drug Metab Dispos; 2010 Dec; 38(12):2096-9. PubMed ID: 20729274
[TBL] [Abstract][Full Text] [Related]
56. A unique downregulation of h2-calponin gene expression in Down syndrome: a possible attenuation mechanism for fetal survival by methylation at the CpG island in the trisomic chromosome 21.
Kuromitsu J; Yamashita H; Kataoka H; Takahara T; Muramatsu M; Sekine T; Okamoto N; Furuichi Y; Hayashizaki Y
Mol Cell Biol; 1997 Feb; 17(2):707-12. PubMed ID: 9001224
[TBL] [Abstract][Full Text] [Related]
57. Human carbonyl reductase (CBR) localized to band 21q22.1 by high-resolution fluorescence in situ hybridization displays gene dosage effects in trisomy 21 cells.
Lemieux N; Malfoy B; Forrest GL
Genomics; 1993 Jan; 15(1):169-72. PubMed ID: 8432528
[TBL] [Abstract][Full Text] [Related]
58. Down syndrome--a gene dosage disease caused by trisomy of genes within a small segment of the long arm of chromosome 21, exemplified by the study of effects from the superoxide-dismutase type 1 (SOD-1) gene.
Annerén G; Edman B
APMIS Suppl; 1993; 40():71-9. PubMed ID: 8311993
[TBL] [Abstract][Full Text] [Related]
59. Mapping of a novel human carbonyl reductase, CBR3, and ribosomal pseudogenes to human chromosome 21q22.2.
Watanabe K; Sugawara C; Ono A; Fukuzumi Y; Itakura S; Yamazaki M; Tashiro H; Osoegawa K; Soeda E; Nomura T
Genomics; 1998 Aug; 52(1):95-100. PubMed ID: 9740676
[TBL] [Abstract][Full Text] [Related]
60. Tetrasomy 21 pter-->q22.1 and Down syndrome: molecular definition of the region.
Daumer-Haas C; Schuffenhauer S; Walther JU; Schipper RD; Porstmann T; Korenberg JR
Am J Med Genet; 1994 Dec; 53(4):359-65. PubMed ID: 7532356
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
